{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:27:29Z","timestamp":1759624049141,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.ejogrb.2009.12.034","type":"journal-article","created":{"date-parts":[[2010,1,21]],"date-time":"2010-01-21T04:39:39Z","timestamp":1264048779000},"page":"215-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The risk of CIN II or greater in a one-year follow-up period in patients with ASC-H interpreted with cytology"],"prefix":"10.1016","volume":"149","author":[{"given":"Ke","family":"You","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanli","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Gen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2009.12.034_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","article-title":"Estimating the world cancer burden: globocan 2000","volume":"94","author":"Parkin","year":"2001","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2009.12.034_bib2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000326384","article-title":"Population based cervical screening with a 5-year interval in The Netherlands. Stabilization of the incidence of squamous cell carcinoma and its precursor lesions in the screened population","volume":"48","author":"Siemens","year":"2004","journal-title":"Acta Cytol"},{"issue":"October (4)","key":"10.1016\/j.ejogrb.2009.12.034_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/LGT.0b013e318159408b","article-title":"2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ","volume":"11","author":"Wright","year":"2007","journal-title":"J Low Genit Tract Dis"},{"issue":"March (1)","key":"10.1016\/j.ejogrb.2009.12.034_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/01.grf.0000151571.91814.f3","article-title":"Management of women with cervical cytology interpreted as ASC-US or as ASC-H","volume":"48","author":"Cox","year":"2005","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2009.12.034_bib5","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.vaccine.2008.05.064","article-title":"Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia","volume":"26","author":"Bosch","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ejogrb.2009.12.034_bib6","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.vaccine.2006.06.018","article-title":"Chapter 5: updating the natural history of HPV and anogenital cancer","volume":"24","author":"Moscicki","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ejogrb.2009.12.034_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","article-title":"Natural history of cervical intraepithelial neoplasia: a critical review","volume":"12","author":"Ostor","year":"1993","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ejogrb.2009.12.034_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.bjc.6603210","article-title":"HPV testing in routine cervical screening: cross-sectional data from the ARTISTIC trial","volume":"95","author":"Kitchener","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejogrb.2009.12.034_bib9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ijc.21897","article-title":"Randomized controlled trial of human papillomavirus testing versus pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the canadian cervical cancer screening trial (CCCaST)","volume":"119","author":"Mayrand","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2009.12.034_bib10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.AOG.0000109426.82624.f8","article-title":"Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening","volume":"103","author":"Wright","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2009.12.034_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1479-828X.2007.00701.x","article-title":"High-risk human papillomavirus DNA testing and high-grade cervical intraepithelial lesions","volume":"47","author":"You","year":"2007","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2009.12.034_bib12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1309\/JM3V-U4HP-W8HJ-68XV","article-title":"Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL triage study","volume":"116","author":"Sherman","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ejogrb.2009.12.034_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/dc.10303","article-title":"Reporting of atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion (ASC-H) on cervical samples: is it significant?","volume":"29","author":"Selvaggi","year":"2003","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.ejogrb.2009.12.034_bib14","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.vaccine.2006.05.026","article-title":"Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases","volume":"24","author":"Clifford","year":"2006","journal-title":"Vaccine"},{"issue":"August (3)","key":"10.1016\/j.ejogrb.2009.12.034_bib15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and highgrade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2009.12.034_bib16","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ajog.2003.09.054","article-title":"Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization","volume":"190","author":"Chao","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"December (6)","key":"10.1016\/j.ejogrb.2009.12.034_bib17","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.ajog.2004.06.088","article-title":"Persistence of human papillomavirus infection as a predictor for recurrence in carcinoma of the cervix after radiotherapy","volume":"191","author":"Nagai","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2009.12.034_bib18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/cncr.23121","volume":"111","author":"Bonvicino","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejogrb.2009.12.034_bib19","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jnci\/djj209","article-title":"Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial","volume":"98","author":"Ronco","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejogrb.2009.12.034_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jcp.57.1.68","article-title":"Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population","volume":"57","author":"Cuschieri","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ejogrb.2009.12.034_bib21","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"Chapter 2: the burden of HPV-related cancers","volume":"24","author":"Parkin","year":"2006","journal-title":"Vaccine"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211510000047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211510000047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:23:01Z","timestamp":1759555381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211510000047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0301211510000047"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2009.12.034","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The risk of CIN II or greater in a one-year follow-up period in patients with ASC-H interpreted with cytology","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2009.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}